LadRx Corp (LADXD)

[ice1234]

CytRx to Present Global Phase 3 Aldoxorubicin Clinical Data in Patients with Soft Tissue Sarcomas at the 2017 American Society of Clinical Oncology Annual Meeting
Oral Presentation Highlighting Updated and More Detailed Results from Global Phase 3 Trial in STS

Results Continue to Demonstrate Significantly Prolonged PFS in North American and L-sarcoma Patients Compared to Standard Treatments, with Minimal or No Cardiotoxicity up to 40 Cycles

Poster Presentation Featuring Data from Phase 1/2 Trial Combining Aldoxorubicin with Ifosfamide/Mesna in First- and Second-Line STS Will Also Be Presented

http://www.prnewswire.com/news-releases/cytrx-to-present-global-phase-3-aldoxorubicin-clinical-data-in-patients-with-soft-tissue-sarcomas-at-the-2017-american-society-of-clinical-oncology-annual-meeting-300459626.html